Table 3: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer.

AuthorYearNOS(months)PFS(months)
MedianMeanMedianMean

Deraco et al. [97]20012721.8
Zanon et al. [98]20043028.1
Raspagliesi et al. [99]20064041.423.9
Helm et al. [100]2007183110
Di Giorgio et al. [101]20082522.515.5
Fagotti et al. [102]20092510
Carrabin et al. [103]2010810
Spiliotis et al. [86]20112519.514.5

OS: overall survival; PFS: progression-free survival.